Holen Sie sich die Stockscreener-App
5.00
4.94%
-0.26
Schlusskurs vom Vortag:
$5.26
Offen:
$5.27
24-Stunden-Volumen:
43,829
Relative Volume:
0.57
Marktkapitalisierung:
$37.92M
Einnahmen:
$27.70M
Nettoeinkommen (Verlust:
$-13.25M
KGV:
-3.0864
EPS:
-1.62
Netto-Cashflow:
$-7.66M
1W Leistung:
-0.20%
1M Leistung:
+1.83%
6M Leistung:
-9.42%
1J Leistung:
-36.71%
1-Tages-Spanne:
$4.9701
$5.38
1-Wochen-Bereich:
$4.855
$5.38
52-Wochen-Spanne:
$4.16
$19.49
Electrocore Inc Stock (ECOR) Company Profile
Firmenname
Electrocore Inc
Sektor
Branche
Telefon
973-290-0097
Adresse
200 FORGE WAY, ROCKAWAY
Vergleichen Sie ECOR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ECOR
Electrocore Inc
|
5.00 | 42.06M | 27.70M | -13.25M | -7.66M | -1.62 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-08-14 | Hochstufung | BTIG Research | Neutral → Buy |
| 2019-11-14 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-09-26 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2019-05-30 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2019-05-15 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-05-09 | Eingeleitet | Noble Capital Markets | Outperform |
| 2018-09-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Electrocore Inc Aktie (ECOR) Neueste Nachrichten
Real time pattern detection on electroCore Inc. stockJuly 2025 Volume & Smart Allocation Stock Reports - newser.com
Real time social sentiment graph for electroCore Inc.Portfolio Update Summary & Free Risk Controlled Daily Trade Plans - newser.com
Can machine learning forecast electroCore Inc. recoveryOil Prices & Community Verified Trade Signals - newser.com
What analysts say about electroCore Inc stockMerger & Acquisition Updates & Free Unlock Rapid Growth Potential - earlytimes.in
ElectroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(4) - MarketScreener
How electroCore Inc. (43E0) stock trades after rate cutsQuarterly Investment Review & Real-Time Volume Spike Alerts - newser.com
Using AI based signals to follow electroCore Inc.Take Profit & Consistent Growth Equity Picks - newser.com
Can electroCore Inc. stock surprise with earnings upsideJuly 2025 Recap & High Accuracy Investment Entry Signals - newser.com
Is electroCore Inc. trending in predictive chart modelsJuly 2025 Momentum & Short-Term Swing Trade Alerts - newser.com
electroCore (ECOR) Files to Sell 762,508 Shares of Common Stock - GuruFocus
Electrocore Finalizes Stock Sale to Settle Legal Fees - TipRanks
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) - The Manila Times
10,000 RSUs: electroCore hires Jennifer Hayes as VP HR; grant vests 1/3 annually from Oct 6, 2025 - Stock Titan
Should You Invest in Medinova Diagnostic Services Limited Before Its Next Earnings ReportPrice Action Trading & Minimal Capital Trading Tips - earlytimes.in
What drives electroCore Inc 43E0 stock priceLong-Term Investment Plans & Affordable Investment Strategies - earlytimes.in
gammaCore® Non-Invasive Vagus Nerve Stimulation (nVNS) as - GlobeNewswire
electroCore’s Board Elects New Chairman - Medical Product Outsourcing
gammaCore® Non-Invasive Vagus Nerve Stimulation (nVNS) as an Adjunctive Treatment Associated with Improvements in Persistent Post-Concussion Symptoms - Yahoo Finance
34% Recovery Rate: electroCore's Non-Invasive Brain Treatment Shows Promise for 2.5M Annual TBI Patients - Stock Titan
What drives electroCore Inc stock priceDividend Stock Watch & Start Your Free Trading Journey Today - earlytimes.in
ECOR Gains Coverage for gammaCore Sapphire in Belgium - GuruFocus
Electrocore announces reimbursement approval for gammaCore by Riziv/Inami in Belgium - MarketScreener
electroCore Announces Reimbursement Approval for gammaCore™ by RIZIV/INAMI in Belgium - GlobeNewswire
Major Reimbursement Win: electroCore's gammaCore Headache Device Gets National Coverage in Belgium - Stock Titan
Is electroCore Inc. (43E0) stock a buy before new product rolloutAnalyst Downgrade & Entry and Exit Point Strategies - newser.com
What technical models suggest about electroCore Inc.’s comebackEarnings Overview Summary & Consistent Growth Stock Picks - newser.com
electroCore Partners With Former Jets Linebacker for Truvaga Awareness - Medical Product Outsourcing
Maxim Group Maintains ElectroCore(ECOR.US) With Buy Rating, Maintains Target Price $12 - 富途牛牛
Digital Migraine Treatment Devices Market to Reach USD 298.71 Million by 2030, Fueled by Non-Invasive Neuromodulation and Expanding Clinical Adoption | DataM Intelligence - 富途牛牛
Finanzdaten der Electrocore Inc-Aktie (ECOR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Electrocore Inc-Aktie (ECOR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Goldberger Daniel S | Chief Executive Officer |
Aug 11 '25 |
Buy |
4.23 |
1,000 |
4,230 |
291,565 |
| GANDOLFO JOHN P | Director |
May 23 '25 |
Buy |
5.01 |
1,800 |
9,018 |
69,087 |
| Errico Thomas J. | Director |
May 12 '25 |
Buy |
4.77 |
10,000 |
47,735 |
266,401 |
1.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):